Cite
HARVARD Citation
Macaluso, F. et al. (2021). The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches. Inflammatory bowel diseases. 27 (2), pp. 182-189. [Online].